Insulin-like growth factor-I and -II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro

Growth Regulation

Volumn 6, Issue 2, 1996, Pages 110-120

  Korbonits, M ^a   Little, J A ^b   Camacho Hubner, C ^b   Trainer, P J ^a   Besser, G M ^a   Grossman, A B ^b  

^a Department of Endocrinology ^*

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Feedback; GHRH; Hypothalamus; IGF I; IGF II; Somatostatin

Indexed keywords

BETA GALACTOSIDASE; GROWTH FACTOR; GROWTH HORMONE RELEASING FACTOR; INSULIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C DERIVATIVE; SOMATOSTATIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; GROWTH HORMONE RELEASE; HORMONE RELEASE; HYPOTHALAMUS; IN VITRO STUDY; MALE; NEGATIVE FEEDBACK; NONHUMAN; RAT;

ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; DEPRESSION, CHEMICAL; FEEDBACK; GROWTH HORMONE-RELEASING HORMONE; HYPOGLYCEMIC AGENTS; HYPOTHALAMUS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTOR, IGF TYPE 2; SOMATOSTATIN;

EID: 0029954328     PISSN: 0956523X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Dieguez C, Page M D, Scanion M F. Growth hormone neuroregulation and its alterations in disease states. Clin Endocrinol 1988; 28: 109-143.
2. Berelowitz M, Firestone S, Frohman L A. Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on somatostatin distribution. Endocrinology 1981; 109: 714-719.
3. Rogers K V, Vician L, Steiner R A, Clifton D K. The effect of hypophysectomy and growth hormone administration on pre-prosomatostatin messenger ribonucleic acid in the periventricular nucleus of the rat hypothalamus. Endocrinology 1988; 122: 586-591.
4. Sheppard M C, Kronheim S, Pimstone B L. Stimulation by growth hormone of somatostatin release from rat hypothalamus in vitro. Clin Endocrinol 1978; 9: 583-586.
5. Conway S, McCann S M, Knilich L. On the mechanism of growth hormone autofeedback regulation: possible role of somatostatin and growth hormone-releasing factor. Endocrinology 1985; 117: 2284-2292.
6. Sato M, Frohman L A. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology 1993; 133: 793-799.
7. Bertherat J, Timsit J, Bluet-Pajot M T et al. Chronic growth hormone (GH) hypersécrétion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat. J Clin Invest 1993; 91: 1783-1791.
8. Mitsugi N, Arita J, Kimura F. Effects of intracerebroventricular administration of growth hormone-releasing factor and corticotropin-releasing factor on somatostatin secretion into rat hypophysial portal blood. Neuroendocrinology 1990; 51: 93-96.
9. Aguila M C, McCann S M. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism. Endocrinology 1985; 117:762-765.
10. Katakami H, Downs T R, Frohman L A. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat. Endocrinology 1988; 123: 1103-1109.
11. Yamauchi N, Shibasaki T, Ling N, Demura H. In vitro release of growth hormone-releasing factor (GRF) from the hypothalamus: somatostatin inhibits GRF release. Regul Pept 1991; 33: 71-78.
12. Slama A, Bluet-Pajot M T, Mounier F, Videau C, Kordon C, Epelbaum J. 125I-somatostatin-labeled cells in the anterior arcuate nucleus mediate somatostatin effects on growth hormone but not prolactin secretion. Neuroendocrinology 1993; 58: 178-184.
13. Willoughby J O, Brogan M, Kapoor R. Hypothalamic interconnections of somatostatin and growth hormone releasing factor neurons. Neuroendocrinology 1989; 50: 584-591.
14. Epelbaum J. Anatomical and physiological interactions between GHRH and SRIF neurons. Neuroendocrinology 1994; 60: 3(abstr).
15. Lumpkin M D, Samson W K, McCann S M. Effects of intraventricular growth hormone-releasing factor on growth hormone release: further evidence for ultrashort loop feedback. Endocrinology 1985; 116: 2070-2074.
16. Richardson S B, Twente S. Inhibition of rat hypothalamic somatostatin release by somatostatin: evidence for somatostatin ultrashort loop feedback. Endocrinology 1986; 118: 2076-2082.
17. Epelbaum J, Tapia-Arancibia L, Alonso G, Astier H, Kordon C. The anterior periventricular hypothalamus is the site of somatostatin inhibition on its own release: an in vitro and immunocytochemical study. Neuroendocrinology 1986; 44: 255-259.
18. Horvâth S, Palkovits M. Synaptic interconnections among growth hormone-releasing hormone (GHRH)-containing neurons in the arcuate nucleus of the rat hypothalamus. Neuroendocrinology 1988; 48: 471-476.
19. Pontiroli A E, Lanzi R, Monti L D, Sandoli E, Pozza G. Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin. J Clin Endocrinol Metab 1991; 72: 492-495.
20. McDonnel K J, Peisen J N, Lumpkin M D. Evidence for GABA mediation of growth hormone-releasing hormone ultrashort-loop feedback inhibition in the hypothalamus. 76th Annual Meeting of the Endocrine Society, Anaheim, CA, 1994; 268-270(abstr).
21. Berelowitz M, Szabo M, Frohman L A, Firestone S, Chu L, Hintz H L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1981; 212: 1279-1281.
22. Goodyer C G, DeStephano L D, Guyda H J, Posner B I. Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture. Endocrinology 1984; 115: 1568-1576.
23. Namba H, Morita S, Melmed S. Insulin-like growth factor-I action on growth hormone secretion and messenger ribonucleic acid levels: interaction with somatostatin. Endocrinology 1989; 124: 1794-1799.
24. Binoux M, Hossenlopp P, Lassare C, Hardouin N. Production of insulin-like growth factors and their carrier by rat pituitary gland and brain expiants in culture. FEES Lett 1982; 124: 178
25. Frank H J L, Pardridge W M, Morris W L, Rosenfeld R G, Choi T B. Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes 1986; 35: 654-661.
26. Reinhardt R R, Bondy C A. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994; 135: 1753-1761.
27. Lengyel A J, Grossman A B, Niewenhuyzen-Kruseman A C, Ackland J, Rees L H, Besser G M. Glucose modulation of somatostatin and LHRH release from rat hypothalamic fragments in vitro. Neuroendocrinology 1984; 39: 31-38.
28. Tsagarakis S, Ge F, Rees L H, Besser G M, Grossman A B. Stimulation of alpha-adrenoceptors facilitates the release of growth hormone-releasing hormone from rat hypothalamus in vitro. J Neuroendocrinol 1989; 1: 129-133.
29. Berelowitz M, Dudlak D, Frohman L A. Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. Effects of glucose and glucoregulatory hormones. J Clin Invest 1982; 69: 1293-1301.
30. Lengyel A J, Grossman A B, Bouloux G, Rees L H, Besser G M. Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro. J Endocrinol 1985; 106: 317-322.
31. Shibasaki T, Yamauchi N, Hotta M et al. In vitro release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor-1. Regul Pept 1986; 15: 47-53.
32. Honegger J, Spagnoli A, D'Urso R et al. Interleukin-1β modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect. Endocrinology 1991; 129: 1275-1282.
33. Aguila M C, Boggaram V, McCann S M. Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels. Brain Res 1993; 625: 213-218.
34. Tijssen P, Kurstak E. Highly efficient and simple methods for the preparation of peroxidase and active peroxidase-antibody conjugates for enzyme immunoassays. Anal Biochem 1984; 134: 451-457.
35. Hossenlop P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138-143.
36. Camacho-Hübner C, Busby W H, McCusker R H, Wright G, Clemmons D R. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanism that reeulate their secretion. J Biol Chem 1992; 267: 11949-11956.
37. Sara V R, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990; 70: 591-613.
38. Goodyer C G, DeStephano L D, Lai W H, Guyda H J, Posner B I. Characterization of insulin-like growth factor receptors in rat pituitary, hypothalamus, and brain. Endocrinology 1984; 114: 1187-1195.
39. Bohannon N J, Figlewicz D P, Corp E S, Wilcox B J, Porte B J, Baskin D G. Identification of binding sites for an insulin-like growth factor (IGF I) in the median eminence of the rat brain by quantitative autoradiography. Endocrinology 1986; 119: 943-945.
40. Lesniak M A, Hill J M, Kiess W, Rojeski M, Pert C B, Roth J. Receptors for insulin-like growth factors I and II: autoradiographic localization and comparison to'receptors for insulin. Endocrinology 1988; 123: 2089-2099.
41. Nissley S P, Lopaczynski W. IGF receptors. Growth Factors 1991; 5: 29-43.
42. Perdue J F, Bach L A, Hashimoto R, et al. Structural determinants for the binding of insulin-like growth factor-II to IGF and insulin receptors and IGF binding proteins. In: Baxter R C, Gluckman P D, Rosenfeld R G, eds. The insulin-like growth factors and their regulatory proteins. Amsterdam: Elsevier, 1994: 67-76.
43. Kiess W, Thomas C L, Sklar M M, Nissley S P. -galactosidase decreases the binding affinity of the insulin-like-growth-factor-II/mannose-6-phosphate receptor for insulin-Iike-growth-factor II. Eur J Biochem 1990; 190: 71-77.
44. Rosenfeld R G, Hoffman A R, Adashi E Y, Fielder P J, Ocrant I, Céda G P. Effects of insulin-like growth factors on neuroendocrine function. In: Savage M O, Bourguignon J, Grossman A B, eds. Frontiers in paediatric endocrinology. Oxford: Blackwell Scientific 1994: 156-160.
45. Céda G P, Davis R G, Rosenfeld R G, Hoffman A R. The growth hormone (GH)-releasing hormone (GHRH)-GH-Somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology 1987; 120: 1658-1662.
46. Vazquez G F, Cacicedo L, Frailes M T, Lorenzo M J, Tolon R M, Franco F S. Growth hormone-releasing factor regulation by somatostatin, growth hormone and insulin-like growth factor I in fetal rat hypothalamic-brain stem cell cocultures. Neuroendocrinology 1993; 58: 655-665.
47. Uchiyama T, Kaji H, Abe H, Chihara K. Negative regulation of hypothalamic growth hormone-releasing factor messenger ribonucleic acid by growth hormone and insulin-like growth factor I. Neuroendocrinology 1994; 59; 441-450.
48. Harel Z, Tannenbaum G S. Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion. Endocrinology 1992; 131: 758-764.
49. Tannenbaum G S, Guyda H J, Posner B I. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science 1983; 220: 77-79.
50. Spencer G S, Berry C, Hodgkinson S C, Bass J J. On the neuroendocrine role of insulin-like growth factors 1 and 2 in the regulation of growth hormone secretion. Mol Cell Neurosci 1993; 4: 538-542.
51. Guler H P, Zapf J, Froesch E R. Short term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 1987; 317: 137-140.
52. Hartman M L, Clayton P E, Johnson M L et al. A low dose euglycemic infusion of recombinant human insulin-like growth factor-I rapidly suppresses fastingenhanced pulsatile growth hormone secretion in humans. J Clin Invest 1993; 91: 2453-2462.
53. Bermann M, Jaffe C A, Tsai W, DeMott-Frieberg R, Barkan A L. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. J Clin Invest 1994; 94: 138-145.
54. Cotterill A M, Camacho-Hubner C, Holly J M P, Savage M O. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome). Clin Endocrinol 1993; 39: 119-122. 55 .Vaccarello M A, Diamond F B J, GuevaraAguirre J. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency (GHRD)/Laron syndrome. J Clin Endocrinol Metab 1993; 77: 273-280.
55. Trainer P J, Holly J, Medbak S, Rees L H, Besser G M. The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers. Clin Endocrinol 1994; 41: 801-807.
56. Miell J P, Taylor A M, Jones J et al. Administration of human recombinant insulin-like growth factor-I to patients following major surgery. Clin Endocrinol 1992; 37: 542-551.
57. Laron Z, Klinger B, Silbergeld A, Lewin R, Erster B, Gil-Ad I. Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. Acta Endocrinol (Copenh) 1990; 123: 378-382.
58. Torsello A, Ghigo M C, Grilli M, Guidi M, De Gennaro Colonna V, Müller E E. Effects of GH or IGF-I administration on somatostatin and growth hormone-releasing hormone gene expression in the hypothalamus of normal fed and starved rat. 75th Annual Meeting of the Endocrine Society, Las Vegas, NV 1993;479-1714(abstr).
59. Sakano K, Enjoh T, Numata F et al. The design, expression and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation independent mannose 6-phosphate receptor or IGF-I receptor. J Biol Chem 1991; 266: 20626-20635.
60. Ocrant I, Fay C T, Parmelee J T. Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system. Endocrinology 1990; 127: 1260-1267.
61. Pons S, Torres-Aleman I. Basic fibroblast growth factor modulates insulin-like growth factor-I, its receptor, and its binding proteins in hypothalamic cell cultures. Endocrinology 1992; 131: 2271-2278.
62. Conover C A, Clarksin J T, Bale L K. Insulin-like growth factor-11 enhancement of human fibroblast growth via a nonreceptor-mediated mechanism. Endocrinology 1994; 135: 76-82.